HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19.

AuthorsAnkur Kalra, Edward S Hawkins, Amy S Nowacki, Vardhmaan Jain, Alex Milinovich, Joshua Saef, George Thomas, Surafel K Gebreselassie, Sadashiva S Karnik, Lara Jehi, James B Young, Lars G Svensson, Mina K Chung, Neil Mehta
JournalCirculation. Cardiovascular quality and outcomes (Circ Cardiovasc Qual Outcomes) Vol. 13 Issue 10 Pg. e007115 (10 2020) ISSN: 1941-7705 [Electronic] United States
PMID32856462 (Publication Type: Comparative Study, Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
Topics
  • Aged
  • Angiotensin Receptor Antagonists (therapeutic use)
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections (complications, therapy, virology)
  • Female
  • Hospitalization (statistics & numerical data)
  • Humans
  • Hypertension (complications, drug therapy)
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral (complications, therapy, virology)
  • Respiration, Artificial (statistics & numerical data)
  • Retrospective Studies
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: